Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alvelestat dose-finding study in COPD
NCT00949975Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2009
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 2 trial of alvelestat in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Jul 2009; status: completed.
02
Drugs
alvelestat
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00949975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00949975.